Market Value958,088,000
Total Holdings39
File Date2013-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ACAD / ACADIA Pharmaceuticals Inc.
ACAD / ACADIA Pharmaceuticals Inc. Call
US00448Q2012 / Achillion Pharmaceuticals, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc. Call
AGIO / Agios Pharmaceuticals, Inc.
AMPE / Ampio Pharmaceuticals, Inc.
ARROWHEAD RESH CORP / (042797209)
BCRX / BioCryst Pharmaceuticals, Inc.
CCXI / ChemoCentryx Inc
FBIO / Fortress Biotech, Inc. Call
DSCI / Derma Sciences, Inc.
DYAX / Dyax Corp. Call
DYAX / Dyax Corp.
DVAX / Dynavax Technologies Corporation
ENTA / Enanta Pharmaceuticals, Inc.
ENZ / Enzo Biochem, Inc.
EPZM / Epizyme Inc
SGMO / Sangamo Therapeutics, Inc.
SGMO / Sangamo Therapeutics, Inc. Call
BLUE / bluebird bio, Inc.
HPTX / Hyperion Therapeutics Inc
KERX / Keryx Biopharmaceuticals, Inc.
KERX / Keryx Biopharmaceuticals, Inc. Call
MRTX / Mirati Therapeutics, Inc.
MYGN / Myriad Genetics, Inc.
LUMO / Lumos Pharma, Inc.
LUMO / Lumos Pharma, Inc. Call
NVAX / Novavax, Inc.
OCRX / Ocera Therapeutics, Inc.
OMER / Omeros Corporation
ACHV / Achieve Life Sciences, Inc.
PTCT / PTC Therapeutics, Inc.
RCPT / Receptos, Inc.
RMTI / Rockwell Medical, Inc. Put
SAVIENT PHARMACEUTICALS INC / NOTE 4.750% 2/0 (80517QAA8)
SNMX / Senomyx, Inc.
VIRX / Viracta Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
TXMD / TherapeuticsMD, Inc.
TRANZYME INC / (89413J102)
XOMA / XOMA Royalty Corporation
PRTA / Prothena Corporation plc
INSM / Insmed Incorporated